PH 1 TRIAL EVALUATING MRG-106, A MICRORNA-155 INHIBITOR,...

Hematological Oncology 2017 / 06 Vol. 35

PH 1 TRIAL EVALUATING MRG-106, A MICRORNA-155 INHIBITOR, ADMINISTERED BY INTRATUMORAL, SUBCUTANEOUS, OR INTRAVENOUS DELIVERY IN CUTANEOUS T-CELL LYMPHOMA (CTCL) PATIENTS

Querfeld, C., Foss, F.M., Porcu, P., Kim, Y.H., Pacheco, T., Haverkos, B., Halwani, A.S., DeSimone, J., William, B., Pinter-Brown, L., Seto, A., Ruckman, J., Landry, M., Jackson, A.L., Dickinson, B.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_149
Date:
June, 2017
File:
PDF, 88 KB
english, 2017
Conversion to is in progress
Conversion to is failed